Molecular Symphony in Breast Cancer: Insights on Genomic Discoveries and Epigenetic Regulation

Abstract: Mutations that impair regular cell growth and division are the root cause of breast cancer, a complicated genetic disorder. Our knowledge of the disease's molecular foundation has significantly increased as a result of recent genomics developments. This study intends to clarify important driver mutations linked to breast cancer, classify them according to their penetrance, and investigate the consequences for risk evaluation and targeted treatments. A review of recent research was conducted to identify important genetic mutations linked to breast cancer, such as high, moderate, and low penetrance genes. Furthermore, the part epigenetic modifications play in the development of cancer was investigated. Because of their functions in DNA repair and cell cycle regulation, high-penetrance genes like PTEN, TP53, and BRCA1/2 have been connected to an increased risk of breast cancer. The intricacy of the disease is further increased by low penetrance variations and moderate penetrance genes like CHEK2 and BRIP1. The study highlights the significance of understanding these genetic alterations to customize screening and treatment strategies. Furthermore, epigenetic mechanisms like DNA methylation and histone modifications are essential for regulating gene expression and fostering tumor growth. The knowledge gathered from genomic and epigenetic research is essential for refining the estimation of breast cancer risk and creating focused treatment strategies. A comprehensive understanding of these molecular mechanisms will improve clinical outcomes in the treatment of breast cancer by allowing patients to receive more effective care and treatment options.